1. Nature of the Service
Biotech Stock Intel curates, organizes, summarizes, and presents information about publicly traded biotechnology and healthcare companies for general educational and research purposes. The information is derived from publicly available materials such as U.S. Food and Drug Administration announcements and records, company press releases and regulatory filings, clinical-trial records, scientific publications, and other public disclosures.
A free or paid membership provides access to research content, data organization, screening tools, and related informational features. Membership fees are payment for access to these research and educational tools only; they are not deposits, investment funds, brokerage fees, or payment for financial advice or financial services.
2. No financial or investment services
Biotech Stock Intel is not a broker-dealer, investment adviser, financial adviser, securities exchange, bank, fund, or fiduciary. We do not:
- provide personalized investment, financial, trading, legal, tax, accounting, or medical advice;
- recommend, rate, endorse, offer, or solicit the purchase, sale, or holding of securities or financial instruments;
- execute or arrange trades, accept investment orders, hold customer money or securities, or manage or monitor portfolios; or
- promise returns, profits, investment performance, clinical outcomes, regulatory approvals, or any other result.
Content, labels, rankings, screens, calendars, estimates, and other research features are general informational outputs. They are not tailored to any user's financial situation, investment objectives, experience, or risk tolerance and should not be treated as a substitute for advice from an appropriately licensed professional.
3. No recommendation or solicitation
References to a company, security, product candidate, clinical trial, regulatory event, analyst view, market movement, or potential catalyst are provided solely to support independent research. Inclusion, exclusion, prominence, or categorization does not express a view that a security is suitable, attractive, safe, or likely to increase or decrease in value.
No communication from Biotech Stock Intel creates an advisory, brokerage, fiduciary, doctor-patient, or other professional relationship.
4. Information may change or be incorrect
We aim to make the Service useful, but public information can be delayed, revised, incomplete, incorrectly reported, or misunderstood. Dates and events may be postponed, changed, canceled, or announced without notice. We may also summarize, normalize, categorize, calculate, or estimate information, which can introduce differences from the underlying source.
We do not guarantee that any information is accurate, complete, current, correctly classified, continuously available, or fit for a particular purpose. Users should verify important information directly against current primary-source materials before relying on it.
5. Investment and biotechnology risks
Investing involves risk, including the possible loss of all invested capital. Biotechnology and healthcare securities may be especially volatile because of clinical results, safety findings, regulatory decisions, financing and dilution, intellectual-property disputes, manufacturing issues, commercialization outcomes, and changing market conditions. A regulatory milestone, clinical result, historical price movement, analyst target, or prior outcome does not guarantee approval, clinical benefit, commercial success, or future investment performance.
Past performance is not indicative of future results. The Service is not intended for decisions that require real-time information or immediate trade execution.
6. Your responsibility
You are solely responsible for evaluating information and for any decisions you make. Conduct your own research, consider your circumstances and risk tolerance, and consult an appropriately licensed financial, legal, tax, accounting, or medical professional when you need advice. Your use of the Service is also governed by our Terms of Service.